Beyond Achondroplasia

Growing together with Clara

August 15, 2018
by inesp.alves
0 comments

QED Tx – a new company working on a treatment for achondroplasia

At the beginning of 2018, QED Therapeutics was launched by Bridge Bio, as a new biotechnology company, focused on precision medicine for FGFR-driven diseases. 1. What are FGFRs? The fibroblast growth factor receptors (FGFRs) regulate important biological processes including cell proliferation … Continue reading

June 30, 2016
by inesp.alves
0 comments

State of the art in achondroplasia

In the present, achondroplasia has more opportunities in the scientific search for a treatment than almost any other rare disease has. And this is very amazing. There are some relevant points in the science that is being produced for achondroplasia: … Continue reading

June 14, 2016
by inesp.alves
0 comments

Defective development and growth of the mandible in achondroplasia

An embryo is a new organism in the earliest stage of development. In humans this is defined as the developing organism from the fourth day after fertilization (when the union of a human egg and sperm cell occurs) to the end of … Continue reading

Translate »